Evidence map›Paper›PMID 25775471›Full record

ArticlePloS one2015

Cardiovascular involvement in connective tissue disease: the role of interstitial lung disease.

XiaoBing Wang, MeiNa Lou, Yongji Li, WenJing Ye, ZhiYong Zhang, Xiufen Jia, HongYing Shi, XiaoChun Zhu, LiangXing Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

XiaoBing WangDepartment of Rheumalogy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
MeiNa LouDepartment of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Yongji LiDepartment of Rheumalogy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
WenJing YeDepartment of Rheumalogy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
ZhiYong ZhangDepartment of Rheumalogy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Xiufen JiaRadiology Department, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
HongYing ShiDepartment of Preventive Medicine, School of Environmental Science and Public Health, Wenzhou Medical University, Zhejiang, China.
XiaoChun ZhuDepartment of Rheumalogy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
LiangXing WangPneumology Department, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
Wenzhou Medical University · CNFirst Affiliated Hospital of Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to assess cardiovascular involvement in patients with connective tissue disease (CTD), and determine whether interstitial lung disease (ILD) in these patients is associated with elevated cardiovascular risk.

methodsThis study evaluated a retrospective cohort of 436 CTD patients admitted to a large teaching hospital in Zhejiang province, China, along with an additional 436 participants of an annual community health screening conducted in the physical examination center who served as age- and gender-matched controls. Demographic, clinical, serologic and imaging characteristics, as well as medications used by each participant were recorded. Cardiovascular involvement was defined by uniform criteria. Correlations between clinical/serologic factors and cardiovascular involvement were determined by univariate and multivariate analyses.

resultsCTD patients had a significantly higher cardiovascular involvement rate than controls (64.7% vs 23.4%), with higher rates of diabetes, hypertension, and hyperlipidemia, elevated systolic and diastolic pressures, C-reactive protein, total cholesterol, and low-density lipoprotein cholesterol, and lower albumin and high-density lipoprotein cholesterol (all p < 0.05). Furthermore, CTP patients with cardiovascular involvement were significantly older, had higher systolic and diastolic pressures, C-reactive protein, glucose, and uric acid, higher rates of diabetes, hypertension, and use of moderate- to high-dose glucocorticoids, and longer disease duration compared to patients without involvement (all p < 0.05). Moreover, CTD in patients with cardiovascular involvement was more likely to be complicated by ILD (p < 0.01), which manifested as a higher alveolar inflammation score (p < 0.05). In the multivariate analysis, cardiovascular involvement in CTD patients was associated with age, systolic pressure, body mass index, uric acid, disease duration > 2 years, use of moderate- to high-dose glucocorticoids, and ILD with a high alveolar inflammation score.

conclusionCardiovascular involvement is increased in CTD patients, and is associated with ILD with a higher alveolar inflammation score. Thus, early-stage echocardiography and CT scans should be used to detect potential cardiovascular complications in these patients.

Indexed as

AdultAgedCardiovascular DiseasesCase-Control StudiesConnective Tissue DiseasesFemaleHumansLung Diseases, InterstitialMaleMiddle AgedRetrospective StudiesRisk

Identifiers

PMID25775471
PMCPMC4361670
OpenAlexW2075218070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.